Clinical Trial Update: Limiting AAA With Metformin (LIMIT) Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating metformin to limit abdominal aortic aneurysm (LIMIT) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Stanford University | Conditions: Abdominal Aortic Aneurysm | Phase 2 | Status: RECRUITING